LRE MEDICAL GMBH

Their core work

LRE Medical GmbH is a German private company specializing in the development and high-volume manufacture of miniaturized photonic biosensor platforms for diagnostic applications. Their core contribution in EU projects is translating laboratory-scale photonic chip technologies — particularly microfluidic and interferometric sensor designs — into manufacturable, scalable products. They have applied this manufacturing and engineering expertise across two distinct application domains: point-of-care cancer companion diagnostics and field-deployable pathogen detection for aquaculture. Their value to consortia lies not in fundamental research but in bridging the gap between photonics research and real-world product readiness.

What they specialise in

How they've shifted over time

LRE Medical entered H2020 through medical diagnostics, contributing to BIOCDx (2017–2020), a cancer companion diagnostics platform built on biophotonics — a high-stakes, regulated application domain. By 2020, their second project shifted the application entirely to aquaculture and food security, using the same underlying photonic sensing technology (aMZI interferometry, microfluidics, integrated chips) to detect pathogens in salmon farming. This suggests LRE's core competence — manufacturing miniaturized photonic sensors at scale — is sector-agnostic, and they are willing to follow the technology into new markets where the sensor hardware fits.

LRE appears to be positioning its photonic sensor manufacturing capability as a platform technology deployable across industries, moving from regulated medical diagnostics toward faster-moving agri-food and environmental monitoring markets.

How they like to work

LRE Medical has participated in both of its H2020 projects as a consortium partner, never as coordinator, which is consistent with a company that brings specific manufacturing and engineering capability rather than scientific leadership. Their consortia have been small to medium in size (9 unique partners across 2 projects), spanning 4 countries, suggesting focused, technically tight collaborations rather than broad open-network participation. Working with them likely means engaging a reliable industrial partner who handles product engineering and scalability while research-focused partners drive the science.

LRE has collaborated with 9 unique partners across 4 countries over its two projects, indicating a focused European network rather than a broad international one. Their partnerships appear purpose-built per project rather than recurring across consortia.

What sets them apart

LRE Medical stands out as an industrial manufacturing partner in consortia that are otherwise dominated by universities and research institutes — they bring the production-readiness perspective that photonics research groups typically lack. Based in Nördlingen, Germany, they combine German engineering standards with deep familiarity with miniaturized optical and microfluidic systems, making them relevant wherever a photonic sensing concept needs to move from prototype to manufacturable product. For a consortium building a photonics-based diagnostic or sensing device, LRE fills the manufacturing and scalability gap that is often the hardest to solve.

Highlights from their portfolio

• BIOCDx
  The larger of the two projects (EUR 710,000 to LRE), targeting cancer companion diagnostics — a high-value, regulated medical market where photonic biosensor accuracy is critical.
• PHOTO-SENS
  Demonstrates LRE's ability to pivot the same photonic sensor platform into a completely different sector (aquaculture/food safety), signaling sector-agnostic manufacturing capability.